Login to Your Account



Anthera Lowers Sights

IPO Activity Poised to Pop with Anthera, Aveo and Trius on Deck

By Trista Morrison


Monday, March 1, 2010
It's been nearly a month since Ironwood Pharmaceuticals Inc. tested the biotech initial public offering waters, and now three more biotechs are queued up to price IPOs over the next three weeks. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription